Table 3. Biomarker evaluations.
The median OS was not reached in any of the patient populations.
Abbreviations: IGFR1, insulin‐like growth factor 1 receptor; NR, not reached; OS, overall survival; PFS, progression‐free survival; pmTOR, phosphorylated mammalian target of rapamycin; pS6, phosphoS6; SD, standard deviation.